Home About us Editorial board Ahead of print Browse Articles Search Submit article Instructions Subscribe Contacts Login 
  • Users Online: 525
  • Home
  • Print this page
  • Email this page


 
Previous article Browse articles Next article 
LETTER TO EDITOR
J Res Med Sci 2018,  23:46

Hyperimmunoglobulin E syndrome


Department of Allergy and Clinical Immunology, Bou Ali Sina Hospital, Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran

Date of Web Publication30-May-2018

Correspondence Address:
Prof. Javad Ghaffari
Department of Allergy and Clinical Immunology, Bou Ali Sina Hospital, Mazandaran University of Medical Sciences, Pasdaran Boulevard, Sari, Mazandaran
Iran
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jrms.JRMS_40_18

Rights and Permissions

How to cite this article:
Ghaffari J. Hyperimmunoglobulin E syndrome. J Res Med Sci 2018;23:46

How to cite this URL:
Ghaffari J. Hyperimmunoglobulin E syndrome. J Res Med Sci [serial online] 2018 [cited 2022 Mar 5];23:46. Available from: https://www.jmsjournal.net/text.asp?2018/23/1/46/233507



Hashemi et al. recently published an article with title: Hyperimmunoglobulin E syndrome: Genetics, immunopathogenesis, clinical findings, and treatment modalities in your journal that it is a good paper.[1] Despite without limitation for searching, there are not a few of related papers in their working.

Incidence of hyperimmunoglobulin E syndrome (HIGE) is 1/100,000–1/200,000. This syndrome divided into two groups including autosomal dominant with a mutation in signal transducer and activator of transcription-3 (chromosome 17, MIM = 147,060) Type 1 and autosomal recessive with a mutation in dedicator of cytokinesis 8 (chromosome 9, MIM = 243,700) (Type 2).[2]

Mutations of autosomal recessive HIES-like disorders following:

  1. Tyrosine kinase 2 gene, encoded on chromosome 19p13.2 (MIM #611521)
  2. Phosphoglucomutase 3 gene, which encodes an enzyme in the biosynthesis of N-glycans (MIM #615816).[2]


About skin manifestations of HIGE syndrome, we reported a boy (16 years old) of HIGE presented with skin psoriasis disease from 1 year ago. His history was recurrent infections including otitis media, pneumonia, diarrhea, and skin infection. Histologic finding was hyperkeratosis, parakeratosis of acanthotic epidermis with regular elongation of rete ridges.

This is the first report of association or relation between hyperactive immunoglobulin E immunoglobulinemia and psoriasis disorder.[3]

We reported another case of HIGE with recurrent infections and pneumatocele in the left and right of the lung. Because there were multiple large pneumatoceles, there was no possible surgery.[4]

The role of bone marrow transplant has different results. Hematopoietic stem cell transplantation (HSCT) was done for different kinds of HIES, but information and experience about the long-term results of this therapy are little.[2]

Recently, studies suggest that HSCT can improve immunologic parameters and reduce frequency and severity of infections although nonhematologic organ failures are not corrected.[5]

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Hashemi H, Mohebbi M, Mehravaran S, Mazloumi M, Jahanbani-Ardakani H, Abtahi SH, et al. Hyperimmunoglobulin E syndrome: Genetics, immunopathogenesis, clinical findings, and treatment modalities. J Res Med Sci 2017;22:53.  Back to cited text no. 1
    
2.
Ghaffari J, Ahanchian H, Zandieh F. Update on hyper IgE syndrome (HIES). J Pediatr Rev 2014;2:39-46.  Back to cited text no. 2
    
3.
Ghaffari J, Abedian-Kenari S, Ghasemi M, Gohardehi F. Psoriasis in hyper IgE syndrome – A case report. Caspian J Intern Med 2013;4:735-8.  Back to cited text no. 3
    
4.
Ghaffari J, Gharagozloo M, Nazari Z. A case report of hyper IgE syndrome. J Mazand Univ Med Sci 2007;16:155-60.  Back to cited text no. 4
    
5.
Yanagimachi M, Ohya T, Yokosuka T, Kajiwara R, Tanaka F, Goto H, et al. The potential and limits of hematopoietic stem cell transplantation for the treatment of autosomal dominant hyper-IgE syndrome. J Clin Immunol 2016;36:511-6.  Back to cited text no. 5
    



This article has been cited by
1 Human STAT3 variants underlie autosomal dominant hyper-IgE syndrome by negative dominance
Takaki Asano,Joëlle Khourieh,Peng Zhang,Franck Rapaport,András N. Spaan,Juan Li,Wei-Te Lei,Simon J. Pelham,David Hum,Maya Chrabieh,Ji Eun Han,Antoine Guérin,Joseph Mackie,Sudhir Gupta,Biman Saikia,Jamila E.I. Baghdadi,Ilham Fadil,Aziz Bousfiha,Tanwir Habib,Nico Marr,Luckshman Ganeshanandan,Jane Peake,Luke Droney,Andrew Williams,Fatih Celmeli,Nevin Hatipoglu,Tayfun Ozcelik,Capucine Picard,Laurent Abel,Stuart G. Tangye,Stéphanie Boisson-Dupuis,Qian Zhang,Anne Puel,Vivien Béziat,Jean-Laurent Casanova,Bertrand Boisson
Journal of Experimental Medicine. 2021; 218(8)
[Pubmed] | [DOI]



 

Top
Previous article  Next article
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
References

 Article Access Statistics
    Viewed1930    
    Printed43    
    Emailed0    
    PDF Downloaded220    
    Comments [Add]    
    Cited by others 1    

Recommend this journal